文献速递慢性肾脏病水电解质与酸碱遗传性与小管间质肾病

维生素D2补充对健康与CKD者维生素D3代谢的影响

Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-08-02

研究纳入25例CKD(eGFR<60 ml/min per 1.73 m2)和44例非CKD者,均筛查25-羟基维生素D<30 ng/ml,口服维生素D2 50,000 IU每周两次共5周。结果显示维生素D2补充降低25-羟基维生素D3向1,25-二羟基维生素D3转化并诱导维生素D3分解代谢,这些效应在CKD中减弱。

要点

  • 维生素D2补充增加25-羟基维生素D2和总25-羟基维生素D,CKD与非CKD相似。
  • 非CKD者1,25-二羟基维生素D2升高而1,25-二羟基维生素D3降低,总1,25-二羟基维生素D无显著变化。
  • CKD者1,25-二羟基维生素D2、1,25-二羟基维生素D3/25-羟基维生素D3比值和24,25-二羟基维生素D3/25-羟基维生素D3比值变化幅度更小。

核心结论

  • 维生素D2补充降低25-羟基维生素D3向1,25-二羟基维生素D3转化并诱导维生素D3分解代谢,这些效应在CKD中减弱。

研究设计与样本

  • 治疗性干预研究,纳入25例CKD(eGFR<60 ml/min per 1.73 m2)和44例非CKD者,来自三个学术中心。
  • 所有参与者筛查25-羟基维生素D<30 ng/ml,口服维生素D2 50,000 IU每周两次共5周。

主要发现

  • 非CKD者1,25-二羟基维生素D2从2.8±1.3升至32.9±1.4 pg/ml,1,25-二羟基维生素D3从45.6±1.9降至14.6±1.9 pg/ml,总1,25-二羟基维生素D无显著变化。
  • 非CKD者1,25-二羟基维生素D3/25-羟基维生素D3比值从3.0±0.2降至1.7±0.2 pg/ng,24,25-二羟基维生素D3/25-羟基维生素D3比值从115.7±7.8升至195.2±7.9 pg/ng。
  • CKD者1,25-二羟基维生素D2从2.1±1.6升至24.4±1.6 pg/ml(P interaction=0.01),1,25-二羟基维生素D3/25-羟基维生素D3比值从1.8±0.2降至1.1±0.2 pg/ng(P interaction=0.05),24,25-二羟基维生素D3/25-羟基维生素D3比值从72.0±9.1升至110.3±9.3 pg/ng(P interaction<0.001)。
  • 两组成纤维细胞生长因子23和甲状旁腺激素均无显著变化。

临床怎么用

  • CKD患者补充维生素D2后维生素D代谢转化和分解代谢变化减弱,临床评估维生素D状态时需考虑CKD对代谢的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Vitamin D supplements are prescribed to correct low circulating concentrations of 25-hydroxyvitamin D. In CKD, vitamin D metabolism is complicated by decreased conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D by CYP27B1 and possibly decreased conversion of 25-hydroxyvitamin D to 24,25-dihydroxyvitamin D by CYP24A1. The aim of this study was to determine the effects of vitamin D2 supplementation on vitamin D metabolism in health and CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a treatment-only intervention study of 25 individuals with CKD (eGFR<60 ml/min per 1.73 m2) and 44 individuals without CKD from three academic centers, all with screening 25-hydroxyvitamin D <30 ng/ml. Each participant was prescribed vitamin D2 (ergocalciferol) 50,000 IU orally twice weekly for 5 weeks. We tested whether changes in plasma concentrations of vitamin D metabolites and vitamin D metabolic ratios differed by CKD status. Plasma 1,25-dihydroxyvitamin D3-to-25-hydroxyvitamin D3 ratio and 24,25-dihydroxyvitamin D3-to-25-hydroxyvitamin D3 ratio were calculated as estimates of CYP27B1 and CYP24A1 function, respectively. RESULTS: With treatment, plasma 25-hydroxyvitamin D2 and total 25-hydroxyvitamin D concentrations increased similarly for participants with and without CKD. For participants without CKD, 1,25-dihydroxyvitamin D2 increased (2.8±1.3-32.9±1.4 pg/ml), whereas 1,25-dihydroxyvitamin D3 decreased (45.6±1.9-14.6±1.9 pg/ml), resulting in no significant change in total 1,25-dihydroxyvitamin D; 1,25-dihydroxyvitamin D3-to-25-hydroxyvitamin D3 ratio decreased (3.0±0.2-1.7±0.2 pg/ng), and 24,25-dihydroxyvitamin D3-to-25-hydroxyvitamin D3 ratio increased (115.7±7.8-195.2±7.9 pg/ng). Individuals with CKD had lower baseline levels and smaller changes in magnitude for 1,25-dihydroxyvitamin D2 (2.1±1.6-24.4±1.6 pg/ml; P interaction =0.01), 1,25-dihydroxyvitamin D3-to-25-hydroxyvitamin D3 ratio (1.8±0.2-1.1±0.2 pg/ng; P interaction =0.05), and 24,25-dihydroxyvitamin D3-to-25-hydroxyvitamin D3 ratio (72.0±9.1-110.3±9.3 pg/ng; P interaction <0.001). Fibroblast growth factor-23 and parathyroid hormone were not significantly changed in either group. CONCLUSIONS: Vitamin D2 supplementation decreases conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and induces vitamin D3 catabolism as evidenced by changes in D3 metabolites and vitamin D metabolic ratios. These effects occur without significant changes in fibroblast growth factor-23 or parathyroid hormone and are blunted in CKD. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2017_08_02_CJASNPodcast_17_09.mp3.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Batacchi Z, Robinson-Cohen C, Hoofnagle AN, et al. Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD. Clin J Am Soc Nephrol. 2017. PMID: 28768705. doi:10.2215/CJN.00530117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。